The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Polymorphisms in genes OPRM1, β-arrestin 2, STAT6, and COMT and clinical outcome to opioid therapy.
Sara Cros
No relevant relationships to disclose
Cristina Buges
No relevant relationships to disclose
Alba Ginés
No relevant relationships to disclose
Anna Martinez Cardús
No relevant relationships to disclose
Vicenç Ruiz de Porras
No relevant relationships to disclose
Laia Capdevila
No relevant relationships to disclose
Enric Carcereny
No relevant relationships to disclose
Eva Martinez-Balibrea
No relevant relationships to disclose
Albert Abad
No relevant relationships to disclose